Overview

Join us for a 15-minute podcast and two 15-minute Clinical Coffee Break activities to explore both the current challenges and emerging landscape of cancer screening, including how the use of multi-cancer early detection (MCED) screening tests may improve cancer care. You’ll not only discover how to integrate newer cancer screening methods into your practice, but you’ll also learn communication strategies to enhance your overall discussions on cancer screening. Across these 3 activities, expert faculty will deliver evidence-based instruction, offer clinical insights, and present case examples to guide you to earlier cancer diagnoses and potentially improve outcomes.

Learning Objectives

  • Appraise the evolving landscape of cancer screening, including limitations of existing screening methods and guidelines
  • Describe the complementary, or additive, role that blood-based screening can play in the primary care setting, specifically for multi-cancer early detection (MCED)
  • Identify patients who could benefit from MCED and describe the various points in cancer screening and care where MCED could help shape patient outcomes
  • Outline evidence-based communication strategies and practice tools that increase cancer screening rates and improve conversations around diagnosis
     

Courses

Faculty

Tomasz M. Beer, MD, FACP

Deputy Director, OHSU Knight Cancer Institute
Chair, Grover C. Bagby Endowed Chair for Prostate Cancer Research
Professor of Medicine
Division of Hematology/Medical Oncology, School of Medicine

Aparna R. Parikh, MD

Assistant Professor of Medicine
Harvard Medical School
Director of the Global Cancer Care Program
Director of the Young Adult Colon Cancer Program
Massachusetts General Hospital
Boston, MA

John J. Russell, MD, FAAFP

Clinical Professor, Family and Community Medicine
Sydney Kimmel School of Medicine
Thomas Jefferson University
Chair, Family Medicine
Jefferson Health – Abington
Abington, PA

Commercial Supporter

GRAIL, LLC

Education Partner

Pri-Med Institute


Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, or DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. Pri-Med Institute is the accredited provider for this activity.

Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation. Pri-Med Institute and Vindico Medical Education staff have no relevant financial relationships to disclose.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.

Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.